Yajima, Toshitaka
AstraZeneca (Japan)
3 papers on CoChatORCID 0000-0001-8409-4937
Most cited papers
- Verified
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
Birkeland, K. I., Bodegard, J., Eriksson, J. W., Norhammar, A., Haller, H., Linssen, G. C. M., Banerjee, A., Thuresson, M., Okami, S., Garal‐Pantaler, E., et al. (2020) · Diabetes, Obesity and Metabolism
Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 223
- Verified
Cost-effectiveness analysis of initiating type 2 diabetes therapy with a sodium-glucose cotransporter 2 inhibitor versus conventional therapy in Japan
Igarashi, A., Maruyama-Sakurai, K., Kubota, A., Akiyama, H., Yajima, T., Kohsaka, S., & Miyata, H. (2022) · Diabetes Therapy
Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life
Cited by 17
- Verified
Effects of food on the pharmacokinetics of omega-3-carboxylic acids in healthy Japanese male subjects: A phase I, randomized, open-label, three-period, crossover trial
Shimada, H., Nilsson, C., Noda, Y., Kim, H., Lundström, T., & Yajima, T. (2017) · Journal of Atherosclerosis and Thrombosis
Fatty Acid Research and HealthAquaculture Nutrition and Growth
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free